Treatment for eye allergy aims at alleviating the symptoms caused by allergic reactions in the eyes, such as itching, redness, and swelling. Common treatments include antihistamine eye drops, which reduce allergic symptoms, and decongestants, which relieve redness. Steroidal eye drops may be prescribed in worse cases of inflammation. Immunotherapy may also be indicated for the long-term management of certain allergens through desensitization of the immune system.
The eye allergy treatment market size is projected to reach US$ 5.69 billion by 2030 from US$ 3.59 billion in 2022; it is estimated to record a CAGR of 5.9% during 2022–2030.
Top Key Players
Bausch + Lomb, Alcon, AbbVie, Johnson Johnson, Akorn Inc, Nicox, Santen Pharmaceutical Co. Ltd, Teva Pharmaceutical Industries Ltd, Novartis AG
Market Segmentations
By Treatment
- Medication
- Allergy Shots
- Eye Drops
By Indication
- Seasonal and Perennial Allergic Conjunctivitis
- Vernal Keratoconjunctivitis
- Atopic Keratoconjunctivitis
- Contact Allergic Conjunctivitis
- Giant Papillary Conjunctivitis
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacy
- Drug Stores
Moreover, staying away from the known triggers that cause flare-ups- these may include pollen or pet dander-is very helpful to keep eye allergies at bay. With increased awareness, more avenues of treatment are becoming available, and thus it increases the quality of life of the sufferer.
